Winship Cancer Institute of Emory University blood disease experts — including faculty, staff and trainees from Emory, Georgia Tech and Children’s Healthcare of Atlanta — will present emerging pre-clinical, epidemiological and clinical data in blood cancers and blood disorders at the 67th Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, Dec. 6-9, 2025.
With more than 18,000 members representing 100 countries, ASH is the world’s largest professional society serving clinicians and scientists who are working to make progress against blood diseases. Its annual meeting is a global destination for hematology professionals and drew more than 30,000 attendees last year.
From chairing symposia to presenting promising new treatment approaches for blood malignancies and benign blood diseases, Winship investigators will participate in 97 sessions at this year’s meeting. Pre-conference workshops and symposia include the 14th Annual BMT & Cell Therapy Winter Workshop on Dec. 5, which is co-chaired by Winship hematologist Edmund K. Waller, MD, PhD, FACP, and covers unpublished clinical and pre-clinical data relevant to hematopoietic stem cell transplantation and cell therapy.
“As the hematology programs at Winship continue to expand in their national and global prominence in research, patient care and education, it is particularly gratifying to see the record number of abstracts being presented at this year’s ASH meeting,” says Winship physician-researcher David A. Frank, MD, PhD, FACP, director of the Division of Hematology in Emory University School of Medicine’s Department of Hematology and Medical Oncology. “Many of the presenting authors are students or trainees, which reflects the phenomenal teaching and mentorship provided by our faculty. Furthermore, a growing number of the senior authors on the research being presented are in the early stage of their faculty careers. This suggests that the impact of our hematology programs will continue to grow briskly in the years ahead.”
This year, several early-career Winship researchers were selected for special ASH awards that recognize the accomplishments of hematologists-in-training. Hematology and medical oncology fellow Abraham Attah, MD, received a 2025 ASH Hematology Inclusion Pathway (HIP) Fellow Award, which provides salary support and funding for blood science-focused research projects. Attah is also one of the following 20 Emory trainees to receive an ASH Abstract Achievement Award given to presenting authors of high-scoring annual meeting abstracts: